Gregory R. Friberg, EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 3,281 shares at $53.85 ($177K) on 2026-05-07, disclosed to the SEC on 2026-05-11.
Open-market sale of $177k BMRN by EVP, Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.